个人简介
刘孟忠教授，1955年出生。1983年毕业于中山医科大学临床医学系（本科），1988年取得中山医科大学临床肿瘤学硕士学位。医疗业务专长：胸腹部肿瘤、鼻咽癌及前列腺肿瘤的放化综合治疗，具有丰富的临床经验。主要学术成绩包括：食管癌的术前放化疗已开展多中心临床试验，取得很好的进展；在食管癌同期放化疗方案的探索方面，已有论文被NCCN指南采用；在胸腹部肿瘤采用先进的4D-CT\IGRT等放射治疗技术方面处于国内领先水平。承担国家自然基金、省部级课题十余项，并以第一或通讯作者发表论文80余篇，其中有30余篇被SCI收录。并主持参加新药甘氨双唑钠的II、III期临床试验，获得国家新药一类证书。
主要学习工作经历
1983年中山医科大学临床医学系毕业，获学士学位；
1983年开始工作于中山大学附属肿瘤医院，住院医师
1988年中山医科大学肿瘤学研究生毕业，获硕士学位；
1990年获聘中山大学附属肿瘤医院主治医师；
1996年获聘中山大学附属肿瘤医院副主任医师；
2001年获聘中山大学肿瘤防治中心主任医师、教授；
2006年～2015年中山大学肿瘤防治中心放疗科科主任；
2015年至今中山大学肿瘤防治中心放疗科主任导师
近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Luo LL, Zhao L, Wang YX, Tian XP, Xi M, Shen JX, He LR, Li QQ, Liu SL, Zhang P, Xie D, Liu MZ（通讯作者）.Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma.Sci Rep. 2015 Dec 16;5:17336.
2. Luo LL, Zhao L, Xi M, He LR, Shen JX, Li QQ, Liu SL, Zhang P, Xie D, Liu MZ（通讯作者）.Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma.Chin J Cancer. 2015 Sep 14;34(3):47.
3. Zhao L, Chi F, Xi M, Shen JX, Li QQ, He LR, Liu SL, Liu MZ（通讯作者）. Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma.Biomed Pharmacother. 2015 Aug;74:148-52.
4. Zhang P, Xi M, Zhao L, Qiu B, Liu H, Hu YH, Liu MZ（通讯作者）. Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy.RadiotherOncol. 2015 Aug;116(2):257-61.
5. Liu SL, Xi M, Yang H, Yang YD, Wu YJ, Zhao L, Zhang P, Luo LL, Liu MZ（通讯作者）. Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?Ann SurgOncol. 2016 Jan;23(1):273-81.
6. Zhao L, Wang YX, Xi M, Liu SL, Zhang P, Luo LL, Liu MZ（通讯作者）. Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.Int J ClinExpPathol. 2015 May 1;8(5):5753-60.
7. Zhang P, Xi M, Zhao L, Li QQ, He LR, Liu SL, Shen JX, Liu MZ（通讯作者）. Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone.Radiat Oncol. 2014 Nov 26;9:256.
8. Zhang P, Xi M, Li QQ, He LR, Liu SL, Zhao L, Shen JX, Liu MZ（通讯作者）.The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy.J Cancer. 2014 Sep 6;5(8):689-95
9. Zhang P, Xi M, Zhao L, Shen JX, Li QQ, He LR, Liu SL, Liu MZ（通讯作者）. Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma.PLoS One. 2014 Aug 18;9(8):e105270.
10. Zhang P, Xi M, Zhao L, Li QQ, He L, Liu S, Shen J, Liu MZ（通讯作者）.Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma patients undergoing chemoradiotherapy: a retrospective study.PLoS One. 2014 Jun 30;9(6):e101332.
11. Xi M, Liu SL, Zhao L, Shen JX, Zhang L, Zhang P, Liu MZ. Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma.PLoS One. 2013 Dec 18;8(12):e84586.
12. Xi M, Zhang L, Zhao L, Li QQ, Guo SP, Feng ZZ, Deng XW, Huang XY, Liu MZ（通讯作者）.Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.PLoS One. 2013 May 30;8(5):e63864.
13. Xi M, Zhang L, Li QQ, Zhao L, Zhang R, Liu MZ（通讯作者）. Assessing the role of volumetric-modulated arc therapy in hepatocellular carcinoma.J ApplClin Med Phys. 2013 May 6;14(3):4162.
14. Zhao L, He LR, Xi M, Cai MY, Shen JX, Li QQ, Liao YJ, Qian D, Feng ZZ, Zeng YX, Xie D, Liu MZ（通讯作者）.Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.J Transl Med. 2012 Dec 11;10:249.
15. Zhang L, Xi M, Deng XW, Li QQ, Huang XY, Liu MZ（通讯作者）. Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma.J Radiat Res. 2012 Sep;53(5):769-76.
16. Zhao L, Li QQ, Zhang R, Xi M, Liao YJ, Qian D, He LR, Zeng YX, Xie D, Liu MZ（通讯作者）.The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.Tumour Biol. 2012 Aug;33(4):1115-23.
17. Zhao L, He LR, Zhang R, Cai MY, Liao YJ, Qian D, Xi M, Zeng YX, Xie D, Liu MZ（通讯作者）. Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma.Med Oncol. 2012 Dec;29(4):2669-76.
18. Liang SX, Huang XB, Zhu XD, Zhang WD, Cai L, Huang HZ, Li YF, Chen L, Liu MZ（通讯作者）. Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis.RadiotherOncol. 2011 Feb;98(2):265-9
京公网安备 11010802027423号